Although ISBT128 has been widely adopted for blood and cellular therapy, challenges persist in uniquely identifying biologic products during their lifecycle.The unique ID of a Medical Product of Human Origin (MPHO) has previously relied upon combining multiple elements. The lack of standardization of this information within electronic health records (EHRs) or electronic messaging interfaces makes it difficult to maintain product history.The MPHO Unique Identifier provides a harmonized way to capture key traceability data elements in a single unique identifier for data transfer and storage. This ID defines a standardized format that incorporates data fields already present on MPHO labels, including Processing Facility Identification Number, Product Description Code, Donation Identification Number, and Division Identifier, allowing ease in querying.This session will discuss the MPHO Unique Identifier and its successful use in Cellular Therapy, a first for the field.
All relevant financial relationships have been mitigated.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
AM23-MN-32-O: Moving Beyond the Label - How the MPHO Unique Identifier Improves Traceability and Enhances Biovigilance (Enduring) Evaluation